Oncology/Hematology

Prostate Cancer

More in Prostate Cancer

Drug Shortages Hit Oncology; Telemedicine Tops In-Person; Sniffing Out Lung Cancer

News, features, and commentary about cancer-related issues

May 12, 2023
Onco Break over a computer rendering of a cancer cell.
World's Smallest Skin Cancer; Exercise Boosts Immune Cells; Cannabis and Pain Relief

News, features, and commentary about cancer-related issues

May 05, 2023
Onco Break over a computer rendering of a cancer cell.
Enzalutamide-ADT Cuts Risk for Disease Spread in Nonmetastatic Prostate Cancer

Combo has potential to be new standard of care in patients with high-risk BCR, expert says

Apr 30, 2023
AUA over a photo of McCormick Place in Chicago, Illinois
FDA Panel Rejects Broad Olaparib Indication in Metastatic CRPC

ODAC votes that olaparib-abiraterone combination should be restricted to BRCA-positive subset

Apr 28, 2023
FDA olaparib (Lynparza) + abiraterone (Zytiga) over a computer rendering of prostate cancer.
Vit D and PD-1 Blockade; Low Implant-Related SCC Risk; Better Pay for Unused Meds

News, features, and commentary about cancer-related issues

Apr 28, 2023
Onco Break over a computer rendering of a cancer cell.
FDA Staff Not Sold on Broad Olaparib Indication in Metastatic CRPC

Agency asking ODAC if olaparib-abiraterone should be reserved for BRCA-positive subset

Apr 27, 2023
FDA olaparib (Lynparza) + abiraterone (Zytiga) over a computer rendering of prostate cancer.
Talc-Cancer Lawsuits on Hold; Diet & Prostate Cancer; Active Surveillance Deep Dive

News, features, and commentary about cancer-related issues

Apr 21, 2023
Onco Break over a computer rendering of a cancer cell.
Robust PSA Drops With Radionuclide Therapy in Castration-Resistant Prostate Cancer

All but one patient had a PSA decline after a fractionated dose of 225Ac-J591

Apr 18, 2023
AACR over a photo of Orange County Convention Center in Orlando, Florida.
Older Men Still Overscreened for Prostate Cancer, Survey Says

PSA screening rates over 50% for men 70 and up, despite USPSTF recommendations against it

Apr 11, 2023
A photo of a test tube of blood laying on a test form with an X in the box next to PSA
Prenatal Thalidomide and Cancer Risk; MDS Combo Shows Promise; Symptoms Often Missed

News, features, and commentary about cancer-related issues

Mar 31, 2023
Onco Break over a computer rendering of a cancer cell.
'Cancer Alley' Lawsuit; Brown Fat and Survival; Moral Distress in Radiology

News, features, and commentary about cancer-related issues

Mar 23, 2023
Onco Break over a computer rendering of a cancer cell.
Shortage of Prostate Cancer Drug; Win for DBT Mammo; Double Lung Transplant

News, features, and commentary about cancer-related issues

Mar 16, 2023
Onco Break over a computer rendering of a cancer cell.
Deaths From PSA-Detected Prostate Cancer Low at 15 Years, No Matter the Treatment

Consider "trade-offs" between harms and benefits of treatments, say researchers

Mar 11, 2023
A photo of surgeons performing a prostatectomy
Economic Impact of Obesity; Tap Water Burns

Also in TTHealthWatch: low-risk prostate cancer in the U.S.

Mar 11, 2023
TTUHSC EL PASO HEALTHWATCH with their logo and photos of Rick Lange, MD, and Elizabeth Tracey
More in Prostate Cancer

Continuing Medical Education

0.50 CME Credits
Optimizing Outcomes in Gastroesophageal Cancers: Expert Insights on Novel Biomarkers and Therapies

1.00 CME Credits
A Deep Dive on Novel and Emerging Evidence in the Treatment of HR+/HER2- Breast Cancer

1.00 CME Credits
Leveraging Expert-Informed Adverse Event Management and Supportive Care Strategies to Improve Patient Outcomes in Bladder Cancer

0.50 CME Credits
Integrating Novel Classes of Immunotherapy Into Treatment Paradigms in Advanced/Metastatic Melanoma

0.50 CME Credits
Immunotherapy in Advanced Melanoma: Evidence-Based Adverse Event Management Strategies to Improve Patient Outcomes

1.00 CME Credits
Expert Perspectives in Managing Lower-Risk Myelodysplastic Syndromes

1.00 CME Credits
Incorporating Recent Data Into Current Treatment Paradigms in Melanoma

0.50 CME Credits
Evidence-Based Strategies to Improve Outcomes for Patients With Gastroesophageal Cancers